ATI LPN
Pharmacology and the Nursing Process 10th Edition Test Bank
Chapter 4 : Cultural, Legal, and Ethical Considerations Questions
Question 1 of 5
During a busy night shift, a new nurse administered an unfamiliar medication without checking it in a drug handbook. Later that day, the patient had a severe reaction because he has renal problems, which was a contraindindation to that drug. The nurse may be liable for which of these?
Correct Answer: B
Rationale: Negligence is the failure to act in a reasonable and prudent manner or failure of the nurse to give the care that a reasonably prudent (cautious) nurse would render or use under similar circumstances. Nurses are expected to assess patients thoroughly before medications are given, and to be familiar with medications they are administering. In this case, nursing negligence applies to nurses, not medical negligence. Nonmaleficence is defined as the duty to do no harm, autonomy is defined as the right to make one's own decisions, or self-determination.
Question 2 of 5
The nurse is reviewing the concept of drug polymorphism. Which factors contribute to drug polymorphism?
Correct Answer: B,C,E
Rationale: Inherited factors, diet and nutritional status, and cultural practices are some of the factors that contribute to drug polymorphism. The other options are not factors that contribute to drug polymorphism.
Question 3 of 5
The nurse is performing an admission assessment. Which findings reflect components of a cultural assessment?
Correct Answer: A,C,D,F
Rationale: The past use of medicines, use of herbal treatments, languages spoken, and religious practices and beliefs are components of a cultural assessment. The other options reflect components of a general medication assessment or health history.
Question 4 of 5
During the development of a new drug, which would be included in the study by the researcher to prevent any bias or unrealistic expectations of the new drug's usefulness?
Correct Answer: A
Rationale:
To prevent bias that may occur as a result of unrealistic expectations of an investigational new drug, a placebo is incorporated into the study. The other options are incorrect. FDA approval, if given, does not occur until after phase III. Informed consent is required in all drug studies. Safety information is not determined until the study is under way.
Question 5 of 5
A member of an investigational drug study team is working with healthy volunteers whose participation will help to determine the optimal dosage range and pharmacokinetics of the drug. The team member is participating in what type of study?
Correct Answer: A
Rationale: Phase I studies involve small numbers of healthy volunteers to determine optimal dosage range and the pharmacokinetics of the drug. The other phases progressively involve volunteers who have the disease or ailment that the drug is designed to diagnose or treat.